Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Updated on: March 01,2024

Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Updated on:March 01,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on: March 06,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on:March 06,2024

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e

Updated on: January 30,2024

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e

Updated on:January 30,2024

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Updated on: February 18,2024

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Updated on:February 18,2024

Investigating racial differences in multiple myeloma

by Melissa Rohman,Northwestern UniversityGenome-wide profiling of 5hmC from cfDNA derived from EA and AA patients with MM and its precursors. Genome-wide 5hmC was profiled in patient-derived pla

Updated on: January 22,2024

Investigating racial differences in multiple myeloma

by Melissa Rohman,Northwestern UniversityGenome-wide profiling of 5hmC from cfDNA derived from EA and AA patients with MM and its precursors. Genome-wide 5hmC was profiled in patient-derived pla

Updated on:January 22,2024

Cancer in adolescent and young adult women before pregnancy does not increase risk for stillborn births, study finds

by Deborah Mann Lake,University of Texas Health Science Center at HoustonCredit: Unsplash/CC0 Public DomainAdolescent and young adult women who were diagnosed with cancer and received chemothera

Updated on: January 23,2024

Cancer in adolescent and young adult women before pregnancy does not increase risk for stillborn births, study finds

by Deborah Mann Lake,University of Texas Health Science Center at HoustonCredit: Unsplash/CC0 Public DomainAdolescent and young adult women who were diagnosed with cancer and received chemothera

Updated on:January 23,2024

Researchers find 'unacceptable low' cervical cancer screening rates

by Mayo ClinicHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive

Updated on: June 22,2024

Researchers find 'unacceptable low' cervical cancer screening rates

by Mayo ClinicHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive

Updated on:June 22,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024

Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

by SPIEMicroscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The

Updated on: March 20,2024

Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

by SPIEMicroscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The

Updated on:March 20,2024

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on: May 20,2024

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on:May 20,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on: June 28,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on:June 28,2024

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Updated on: February 23,2024

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Updated on:February 23,2024